business / news / / NDTV Profit
Weight loss drug manufacturer Eli Lilly's market share in India declined in March.
Eli Lilly's market share in India dropped from 61% to 56% in March 2024.
KEY POINTS
- Novo Nordisk's market share in India remained steady at 25% despite generic competition.
- Thirteen Indian companies launched 26 semaglutide brands within weeks of the patent expiry.
- Eli Lilly's Mounjaro is priced at least twice as high as Novo's and ten times generic versions.
- Experts predict further erosion of Eli Lilly's sales as cheaper generics proliferate in the market.
COMPANIES
Summarized by Newsio from NDTV Profit. How we summarize →